A literature survey revealed that the thiouracil derivatives and their condensed heterocycles have occupied a marked position as synthon for various biologically active compounds. They have a wide range of therapeutic uses that include anti-cancer, anti-microbial, molluscicidal, anti-leishmanial, anti-oxidant, anti-viral as anti-HIV and anti-HCV, and antithyroid activities. Numerous methods for the synthesis of thiouracils offer enormous scope in the field of medicinal chemistry. The review article aims to review the work reported for the synthesis and the biological activities of thiouracils and fused thiouracils from the past to recent years.
INTRODUCTION
Heterocyclic compounds are those cyclic compounds whose ring contain besides carbon, one or more atoms of other elements. The non-carbon atoms such rings are referred to as hetero atoms. The most common hetero atoms are nitrogen, sulphur and oxygen. Heterocyclic compounds, bearing atoms of at least two different elements as a member of its ring have attracted considerable attention in the development of pharmacologically active molecules and advanced organic materials. Pyrimidine ring is the building unit of DNA and RNA which explains the fact that pyrimidine derivatives and related fused heterocycles exhibit diverse pharmacological activities. Another important class of pyrimidine is 2-thiopyrimidine (2-TP) and its derivatives. 2-Thiouracil (TU), which is a sulfur-containing uracil, a six membered simple aromatic ring comprises of carbon, two nitrogen atoms at positions 1 and 3, sulfur and oxygen There are two established antithyroid drugs, 6-propyl-2-thiouracil and 6-methyl-2-thiouracil. Thio derivatives of pyrimidine bases including 2-thiouracil, 6-methyl-2-thiouracil, and 2-thiocytosine are minor components of t-RNA, and furthermore, they have contributed remarkably to biological, pharmacological, and medicinal chemistry. Among the pyrimidine containing heterocycles, thiouracils are potential therapeutics as antiviral, anticancer and antimicrobial agents. For example, S-alkylation and N-alkylation products have been recently reported as novel antibacterial, cytotoxic agents and unique HIV reverse transcriptase inhibitors. Moreover, a literature survey revealed that the thiouracil derivatives and their condensed heterocycles have occupied a marked position in the design and synthesis of novel chemotherapeutic agents with remarkable antitumor, HCV inhibitors and antimicrobial activities. During the last two decades, several thiouracil derivatives have been developed as chemotherapeutic agents and have found wide clinical applications. In the light of the aforementioned facts, and in continuation for our interest in the synthesis of biologically active heterocyclic compounds, we report herein the main aspects of the synthesis and the biological value of these heterocycles from the past to recent years.
Synthesis of thiouracils 1.2-Thiouracil
The thiouracil system is constructed either via cyclocondensation of carbonyl compound with thiourea or by introducing thiourea residues into the structure of carbonyl compounds, followed by cyclization of intermediate thio ureides. According to the first synthetic pathway, 2-Thiouracil 1 was prepared by condensation of the enol form of ethyl formyl acetate as its sodium salt with thiourea. This reaction was reported 1 In 2011, Supaluk et al. 4 reported the synthesis of S-substituted thiouracils 5 through the alkylation of 2-thiouracil with alkylating agents (R -Br) in base catalysis (Et3N or K2CO3). In the same year, Ahmed et al. 6 reported the reaction of 2-thiouracils 8 with the hydrochloride salt of diethyl-aminoethyl chloride in KOH to obtain 2-(diethyl amino) ethy-2-thiouracil derivatives 9. In 2016, Dong et al. 7 reported the synthesis of thiouracils 11 by S-alkylation of the 6-substituted 2-thiouracils 10 with the appropriate substituted phenacyl halides in the presence of anhydrous K2CO3.
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In the same year, Makaram et al. 8 reported the reaction of 4-oxo-6-phenyl-2-thioxo-1, 2, 3, 4-tetrahydropyrimidine-5-carbonitrile (12) with chloroacetyl chloride, 2-chlororopionyl chloride, and 3-chloropropionyl chloride in dry benzene using K2CO3 as a base to obtain S-chloro alkanethioates 13. 
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4-Substituted thiouracils
Conversion of 2-thiouracil derivatives 16, 18 to their corresponding 4-chloro analogs 17, 19 using phosphorus oxychloride has been reported [10] [11] [12] [13] or it can be performed using phosphorus oxychloride / phosphorus pentachloride mixture 14, 15 . 
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In 2011, Mosaad et al. 15 reported that a series of 4-alkylamino-2-thiouracils 25 was prepared via reaction of 4-chloro-2-thiouracils 24 with different amines. 
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In 2014, Mosaad et al. 18 reported the synthesis of 4-hydrazino derivatives 27 by reaction of the appropriate chloropyrimidine 26 with 99% hydrazine hydrate in methanol. In 1964, Fissekis et al. 20 reported that 5-(2-hydroxyethyl)-2-thiouracil (29) was prepared by refluxing thiourea with the aqueous solution of the sodium salt of α-formylbutyro lactone in its enolate form. 
6-Substituted thiouracils
In 1999, Maurizio et al. 23 reported the synthesis of thiouracil derivatives 34 via reaction of acetone dicarboxylic acid diethyl ester or ethyl-γ-chloroacetoacetate independently with S-methyl thiourea hydrogen sulphate in presence of calcium hydroxide. 24 reported the reaction of ethyl cyanoacetate with thiourea in sodium ethoxide to prepare 6-amino-2-thioxo-2, 3-dihydro-1H-pyrimidine-4-one (35) . 
5, 6-Disubstituted thiouracils
In 1997, Antonello and his co-workers 25 reported the preparation of a series of 5 and 6-disubstituted thiouracils 37 by condensation of β-oxo esters with thiourea in alcoholic sodium ethoxide.
Many authors [26] [27] [28] reported the formation of 5-cyano-6-aryl-2-thiouracils 38 via cyclocondensation of aromatic aldehydes, thiourea, and ethylcyanoacetate in absolute ethanol /anhy. K2CO3. 
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6-Aryl-5-cyano-2-thiouracils could be also obtained 14, 15, 29 by the reaction of ethyl cyanoacetate, thiourea and aromatic aldehyde in ethanol using sodium ethoxide / ethanol. In 2011, Yan-Ping et al, 34 reported the synthesis of a novel dihydro-alkylsulfanyl-cyclohexyloxopyrimidines 43 through the reaction of β-keto esters and thiourea in sodium ethoxide. In 2012, Mosaad et al. 35 reported the synthesis of a series of mannich bases 45 via the reaction of 5-acetyl-6-methyl-2-thiouracils 44 with paraformaldehyde and primary aromatic amines. 
Synthesis of fused thiouracils
In 2009, Mohamed et al 37 , reported the reaction of 6-aryl-5-cyano-2-thiouracil with chloroacetonitrile in boiling ethanol containing triethylamine to afford 3-aminothiazolo pyrimidine 48; whereas the reaction of thiouracil with dioxalyl chloride gave 2,3,5-trioxothiazolopyrimidine 49. Omar et al, 14, 29 reported the reaction of the hydrazinyl derivatives 50 with ethylchloroformate in refluxing pyridine to afford the desired triazolopyrimidine derivatives 51. In 2013, Mosaad et al. 38 presented that the 4-hydrazinopyrimidine derivatives 58 has also been used as key starting material for the preparation of triazolopyrimidines 59 by the reaction with acetic anhydride. The fused 5-cyano-2-thiouracil derivatives 85-87 induced a significant growth inhibition 14 towards liver cancer (HEPG2) cell line in comparison to 5-flurouracil after treatment with IC50 values (ranged from 3.74 to 8.48 μg/ml concentrations) for each compound while the IC50 value for 5-flurouracil was 5μg/ml concentration. 
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It is demonstrated that the thiouracil analogs 98 is a novel antibacterial. It exerts potent activity 46 against B.catarrhalis with MIC of 32 μg/mL. Thiouracil derivatives 101 showed significant activity against staphylococcus aureus, while compounds102, 103 displayed moderate inhibitory activity 28 against Candida albicans. Moreover, compounds 104 possessed superior antibacterial activity against the gram positive bacteria S.aureus and B.subtilis compared to the reference drug Amoxicillin. Moreover, compound 105 was found to be broad spectrum antimicrobial agent 44 and it also exhibit promising antifungal activity against C.albicans. 4-Oxo-5-cyano thiouracils 116 showed good antimicrobial activity 57 against Escherichia coli mutant strain, NR698 and evaluated as SecA inhibitors. Protein translocation is essential for bacterial survival and the most important translocation mechanism is the secretion (Sec) pathway in which Sec A is a central core driving force. Thus targeting Sec A is a promising strategy for developing novel antibacterial therapeutics. A series of novel 1-(2-mercapto-6-(substituted phenyl) pyrimidine-4-yl)-3-(2-substituted phenyl imino) indolin-2-ones (127) and 1-(2 amino-6-(substituted phenyl)pyrimidine-4-yl)-3-(2-substituted phenyl imino) indolin-2-ones (128) were synthesized and showed more promising antioxidant activity 53 in comparison to standard, butylated hydroxy toluene. 
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The reverse transcriptase (RT) of human immunodeficiency Type 1(HIV-1RT) is one of the main targets for drugs used in the treatment of AIDS, several RT inhibitors have been developed and approved by food and drug administration organization ( FDA) . A series of 5-substituted-2-thiouracils of general formula 132-135 was reported as HIV-1 inhibitor [65] [66] [67] . A series of 2-thiouracil nucleosides 137,138 showed potent and selective antiviral activities 69, 70 against herpes simplex virus (HSV), varicella-zoster virus (VZV) and human cytomegalovirus (HCMV) . A series of novel 2-(phenylaminocarbonyl methylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones 139 have been evaluated for their anti-HIV activities 71 and showed promising activities against wild-type HIV-1. Among them, the most potent HIV-1 inhibitor was 4-bromophenyl derivative (EC50 = 0.18 ± 0.06lM), which was more effective than the reference drugs Nevirapine and Efavirenz. A novel dihydro-aryl/alkylsulfanylcyclohexylmethyl-oxopyrimidines (S-DACOs) 140, 141 were evaluated with C8166 cells infected by the HIV-1IIIB in vitro, using Nevirapine (NVP) and Zidovudine (AZT) as positive control and showed potent anti-HIV activities 34, 72 . 
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